Inventor · disambiguated record
Matti Karvonen
Also filed as: KARVONEN MATTI
5 granted patents·10 pending applications·21 citations·filing 1997–2021
74Inventor score
Files withHORMOS MEDICAL OY LTD3FARON PHARMACEUTICALS OY2HORMOS MEDICAL CORP2JUVANTIA PHARMA LTD OY2HORMOS MEDICAL OY1
Top patents by PatentIndex Score
15 records- 0179US11421279B2Method for determining patient's responsiveness to type 1 interferon treatment and use of type 1 interferon to treat patient having specified single nucleoide polymophismFARON PHARMACEUTICALS OY·Filed 2019·Granted Aug 23, 2022·2 cites·13 claims
- 0259US2009162349A1Method for prevention or treatment of diseases or disorders related to excessive formation of vascular tissue or blood vesselsPHASE ONE PHARMA OY LTD·Filed 2009·Application pending·0 cites
- 0354US2004254131A1Method for prevention or treatment of diseases or disorders related to excessive formation of vascular tissue or blood vesselsFiled 2003·Application pending·0 cites
- 0453US2006154870A1Method for prevention or treatment of diseases or disorders related to excessive formation of vascular tissue or blood vesselsHORMOS MEDICAL CORP·Filed 2006·Application pending·0 cites
- 0553US2005107327A1Method for reducing overproduction of neuropeptide Y in an individualHORMOS MEDICAL CORP·Filed 2004·Application pending·0 cites
- 0652US6046317ADNA molecule encoding a mutant prepro-neuropeptide Y, a mutant signal peptide, and uses thereofHORMOS MEDICAL OY LTD·Filed 1997·Granted Apr 4, 2000·11 cites·7 claims
- 0748US7084242B2DNA molecule encoding a mutant prepro-neuropeptide Y, a mutant signal peptide, and uses thereofHORMOS MEDICAL OY LTD·Filed 2002·Granted Aug 1, 2006·0 cites·2 claims
- 0847US6312898B1Diagnosis of a person's risk of developing atherosclerosis or diabetic retinopathy based on leucine 7 to proline 7 polymorphism in the prepro-neuropeptide Y geneHORMOS MEDICAL OY LTD·Filed 1999·Granted Nov 6, 2001·8 cites·6 claims
- 0946US2004152637A1DNA molecule encoding a variant alpha-2B-adrenoaceptor protein and uses thereofJUVANTIA PHARMA LTD OY·Filed 2004·Application pending·0 cites
- 1043US2005234008A1Diagnosis of a person's risk of developing atherosclerosis or diabetic retinopathy based on leucine 7 to proline 7 polymorphism in the prepro-neuropeptide Y geneHORMOS MEDICAL OY·Filed 2005·Application pending·0 cites
- 1142US2023167173A1Treatment of diseases with clever-1 inhibition in combination with an interleukin inhibitorFARON PHARMACEUTICALS OY·Filed 2021·Application pending·0 cites
- 1241US2003049250A1Method for enhancing endothelial function in humansFiled 2001·Application pending·0 cites
- 1336US2004006004A1Method for prevention and treatment of diseases or disorders related to excessive formation of vascular tissue or blood vesselsFiled 2002·Application pending·0 cites
- 1434US2003224362A1Diagnosis of a person's risk of developing alcoholismFiled 2001·Application pending·0 cites
- 1533US6696556B2DNA molecule encoding a variant α2B-adrenoceptor protein, and uses thereofJUVANTIA PHARMA LTD OY·Filed 2001·Granted Feb 24, 2004·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Matti Karvonen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →